120
Participants
Start Date
January 1, 2023
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
Gabapentin
Weekly dose escalations over 4 weeks of daily 3 x 300 mg up to 3 x 1200 mg
Sulfasalazine
Weekly dose escalations over 3 weeks of daily 3 x 500 mg up to 3 x 1500 mg
Memantine
Weekly dose escalations over 4 weeks of daily 1 x 5-20 mg
Temozolomide
Concomitant with radiotherapy at 75 mg/m2 daily followed by maintenance 150-200 mg/m2 on 5/28 days
Radiotherapy
30 x 2 Gy involved field radiotherapy with concomitant temozolomide
RECRUITING
University Hospital Zurich, Zurich
Swiss National Science Foundation
OTHER
University of Zurich
OTHER